Tetra Radar · FDA Approvals · Decision date
ENFLONSIA: FDA decision date
Merck & Co. Inc (MRK) · 22 March 2027
FDA Accepted sBLA for ENFLONSIA to Update Its RSV LRTD Indication to Include Children Under 2 Years at Increased Risk for Severe RSV for Their Second Season; Based on Results From Phase 3 SMART Trial; FDA Set PDUFA Date of March 22, 2027.
Source: 8-K of 29 October 2026
The decision is pending.
Merck & Co. Inc on Tetra Radar
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.